FIELD: biotechnology.
SUBSTANCE: disclosed is the use of plant exosomes to reduce protein aggregates formed in cells and damage which they cause in the cell.
EFFECT: invention enables to use the product with high efficiency and without side effects, which can be obtained in high quantities and at an acceptable price due to the fact that it is of vegetable origin.
4 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
EXTRACELLULAR VESICLES FOR INHALATION | 2019 |
|
RU2799315C2 |
USE OF PLANT EXOSOMES TO DEMONSTRATE MODULATING EFFECTS ON IMMUNE SYSTEM CELLS | 2019 |
|
RU2806367C2 |
USE OF PARASITES AND EXTRACELLULAR VESICLES DERIVED FROM PARASITES FOR TREATING MALIGNANT TUMOUR | 2020 |
|
RU2814990C2 |
USING SEQUENCE CODING C-TERMINAL HEAVY CHAIN DOMAIN OF TETANUS TOXIN AS THERAPEUTIC AGENT | 2008 |
|
RU2495676C2 |
METHOD OF USING HYDROXYCHLOROQUINE AND DERIVATIVES THEREOF FOR DELIVERING CHEMOTHERAPEUTIC DRUG TO CANCER FOCUS (EMBODIMENTS) | 2023 |
|
RU2834400C2 |
EXOSOME RECOVERY KIT | 2023 |
|
RU2824663C1 |
VESICLES CONTAINING PTEN INHIBITOR AND THEIR USE | 2019 |
|
RU2800729C2 |
TREATMENT METHOD FOR AMYOTROPHIC LATERAL SCLEROSIS | 2023 |
|
RU2804196C1 |
COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) | 2015 |
|
RU2716422C2 |
METHOD FOR PLASMA EXOSOME RELEASE | 2020 |
|
RU2741776C1 |
Authors
Dates
2024-09-25—Published
2020-07-30—Filed